Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer.
Saved in:
| Title: | Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer. |
|---|---|
| Authors: | Deng, Jia-Yi1,2 (AUTHOR), Gao, Ming3 (AUTHOR), Fan, Xue2 (AUTHOR), Yan, Hong-Hong2 (AUTHOR), Luo, Wei-Chi2 (AUTHOR), Yang, Ming-Yi1,2 (AUTHOR), Yang, Xiao-Rong1,2 (AUTHOR), Chen, Zhi-Hong2 (AUTHOR), Xu, Chong-Rui2 (AUTHOR), Zhou, Qing1,2 (AUTHOR) gzzhouqing@126.com |
| Source: | Cancer Immunology, Immunotherapy. May2025, Vol. 74 Issue 6, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03407004 |
|---|---|
| DOI: | 10.1007/s00262-025-03984-7 |
